Encelion LLC v. Whoop: Pulse Sensor Patent Action Voluntarily Dismissed
Encelion LLC filed a patent infringement action against Whoop Inc. in the Delaware District Court, asserting US11471072B2 covering pulse sensor systems and methods. The case was voluntarily dismissed just 15 days after filing — one of the shortest litigation windows recorded at district court level.
A 15-day pulse sensor patent dispute that ended before it began
On 23 March 2026, Encelion LLC filed a patent infringement action against Whoop Inc. in the Delaware District Court (Case No. 1:26-cv-00308), before Judge Gregory B. Williams. The single patent asserted was US11471072B2, directed to a pulse sensor, system, and method for using a pulse sensor — a technology domain directly relevant to wearable fitness and health monitoring devices, the core of Whoop's commercial product line.
The case closed on 7 April 2026, just 15 days after filing. The recorded basis of termination is voluntary dismissal. The docket order states that Encelion LLC invoked Rule 41(a)(1)(A)(i) of the Federal Rules of Civil Procedure to dismiss all claims against Whoop Inc. with prejudice, with each party bearing its own costs, expenses, and attorneys' fees. The notice expressly records that no answer or motion for summary judgment had been filed at the time of dismissal.
A 15-day resolution is exceptionally short and suggests that the parties may have reached an understanding prior to or immediately following the filing. Because the dismissal is with prejudice, Encelion cannot re-file the same claims against Whoop on US11471072B2. The specific terms underlying the resolution — if any exist beyond the filed notice — are not disclosed in the available record.
See Complete Case & Patent Analysis →Filing to Voluntary dismissal in 15 days
Case resolved in 15 days — well below the district court median of several years to trial.
US11471072B2 — Pulse Sensor System and Method
Any company developing or commercialising wearable pulse sensing hardware — including fitness bands, smartwatches, continuous health monitors, and clinical wearables — should consider a freedom-to-operate analysis against US11471072B2. The patent remains in force, has been actively asserted against a market-leading wearable brand, and the absence of any public claim construction means the scope of enforceable claims is untested and unpredictable.
Official order — verbatim text
The dismissal notice invokes Rule 41(a)(1)(A)(i), a unilateral plaintiff mechanism available only before any answer or summary judgment motion is served. The express with-prejudice designation — not the default under a Rule 41(a)(1) notice absent specification — signals a deliberate, final relinquishment of these claims against Whoop. No merits determination was reached, and the cost-neutrality clause leaves both parties in a commercially clean exit position. The underlying commercial rationale is not disclosed in the available record.
Voluntarily dismissed: what the Rule 41 exit means for both parties
Rule 41(a)(1)(A)(i): dismissal before any responsive pleading
Rule 41(a)(1)(A)(i) permits a plaintiff to dismiss an action without a court order before the defendant has served an answer or a motion for summary judgment. The notice here expressly confirms neither had occurred, making this a unilateral plaintiff exit. The dismissal is recorded as with prejudice, meaning the right to re-assert these specific claims is extinguished.
Plaintiff-initiated exitWith prejudice closes the door on US11471072B2 against Whoop
A Rule 41 dismissal can be with or without prejudice. Without prejudice preserves the right to re-file; with prejudice does not. The filed notice in this case specifies dismissal with prejudice. This means Encelion LLC cannot bring the same patent infringement claims based on US11471072B2 against Whoop Inc. in a future action. The reasons for accepting this finality are not disclosed in the available record.
Claims extinguished as to WhoopWhoop exits with no liability finding and no cost exposure
Whoop Inc. faces no court-entered finding of infringement, no damages award, and no injunctive obligation. The cost-bearing clause confirms each party absorbs its own fees, so Whoop incurs no adverse cost order. The with-prejudice nature of the dismissal also provides Whoop with a structural defence against any re-assertion of US11471072B2 by Encelion on the same claims.
No liability, no cost orderUS11471072B2 remains in force and active against other market participants
The voluntary dismissal resolves only the dispute between Encelion and Whoop. US11471072B2 itself is not invalidated, not licensed on the public record, and not exhausted. Other wearable sensor device makers operating in the pulse monitoring space should treat this patent as live enforcement risk. The rapid resolution provides no public signal on claim scope, validity, or infringement theory.
Patent remains enforceableFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | Encelion LLC | Company | /Search in Eureka ↗ |
| Defendant | Whoop | Individual | /Search in Eureka ↗ |
| Plaintiff counsel | Brian E. Lutness | Attorney | Counsel for Encelion LLCSearch in Eureka ↗ |
| Plaintiff law firm | Silverman, McDonald & Friedman | Law Firm | Representing Encelion LLCSearch in Eureka ↗ |
| Presiding judge | Judge Gregory B. Williams | Judge | Delaware District CourtSearch in Eureka ↗ |
R&D signals in the wearable pulse sensor IP space
Forward-looking patent and technology signals for wearable biometric sensing, drawn from the Encelion v. Whoop enforcement action and the broader pulse sensor IP landscape.
Encelion's pulse sensor patent holdings beyond US11471072B2
Encelion's assertion of US11471072B2 against Whoop may represent only a slice of its pulse sensing portfolio. Mapping continuations, divisionals, and related applications filed under the US17/206065 family can reveal whether additional claim sets are being prepared for enforcement against other wearable device makers.
Portfolio mappingFiling trends in wearable pulse and photoplethysmography sensing
Pulse sensing in wearables — particularly optical PPG-based methods — has seen rapid patent filing growth as health monitoring moves from consumer to clinical-grade applications. Tracking filing activity in this domain identifies which companies are building defensive or offensive positions and where white space exists for new innovation.
PPG & pulse sensing trendsWhoop's patent position in continuous biometric monitoring
As the defendant in this action, Whoop's own patent portfolio in continuous biometric sensing, physiological recovery monitoring, and wearable sensor integration is strategically relevant. Understanding Whoop's IP holdings can inform competitive positioning and highlight where its technology may be protectable or exposed to third-party claims.
Whoop IP analysisAdjacent innovation opportunities in non-optical pulse sensing
The enforcement activity around US11471072B2 highlights pulse sensing as a contested IP zone. Adjacent technologies — including radar-based, ultrasonic, or bioelectrical impedance sensing for pulse and heart rate — may represent lower-IP-density spaces for R&D investment and patent filing, offering competitive differentiation without direct infringement risk.
Non-optical sensing white spaceSimilar pulse sensor and wearable biometric patent cases
Explore related patent infringement actions involving pulse sensing, wearable biometric devices, and rapid voluntary dismissals filed in the Delaware District Court.
What this case signals for the wearable biometric sensor IP landscape
A 15-day patent action against a major wearable brand raises pointed questions about enforcement posture and portfolio exposure across the pulse sensing sector.
With-prejudice exit bars re-filing against Whoop — but not others
The with-prejudice dismissal protects Whoop specifically from future Encelion claims on US11471072B2. Other wearable device makers with comparable pulse sensing implementations remain fully exposed. Companies relying on similar sensor architectures should conduct targeted FTO analysis against this patent now, rather than wait for a fresh filing.
No answer filed means no claim construction or validity record exists
Because the case closed before any responsive pleading, there is zero public record on claim scope, infringement mapping, or validity challenges. This information vacuum cuts both ways: it gives Encelion flexibility in future enforcement, and leaves potential defendants without a roadmap for anticipating the infringement theory or assessing litigation risk.
Encelion v Whoop — key questions answered
The case ended by voluntary dismissal. The recorded basis of termination is voluntary dismissal. The docket order reflects that Encelion LLC filed a Rule 41(a)(1)(A)(i) notice dismissing all claims against Whoop Inc. with prejudice, with each party bearing its own costs. No answer or summary judgment motion had been filed at the time of dismissal.
Encelion LLC asserted US11471072B2 (application number US17/206065), which covers a pulse sensor, system, and method for using a pulse sensor. This technology is directly relevant to the wearable continuous health monitoring products that Whoop commercialises.
Based on the filed notice, the dismissal of all claims is stated to be with prejudice. A with-prejudice dismissal under Rule 41 generally bars the plaintiff from re-filing the same claims against the same defendant. The specific terms of any underlying arrangement, if any, are not disclosed in the available record.
A 15-day case duration — from filing on 23 March 2026 to closure on 7 April 2026 — is exceptionally short at district court level. It suggests the matter was resolved very rapidly after filing, before any substantive litigation steps occurred. The specific commercial or legal factors that drove this rapid resolution are not disclosed in the available record.
Yes. The voluntary dismissal resolves only the specific claims between Encelion LLC and Whoop Inc. It does not invalidate US11471072B2, does not create a public license, and does not otherwise limit enforcement against other parties. The patent remains in issued, in-force status and should be treated as an active enforcement risk by other wearable pulse sensing device makers.
This page is compiled from public court dockets and third-party patent and litigation data via PatSnap Eureka, and is provided for general informational purposes only. The information shown — including party names, patent and application numbers, dates, case status, outcomes, and any analysis — may be incomplete, may not reflect the most recent filings or legal status, and may contain errors or omissions. Verify all details against official court records (for example, PACER) and the relevant patent office before relying on them.
Nothing on this page constitutes legal advice or a legal opinion on the validity, infringement, enforceability, or scope of any patent or case, and no attorney‑client relationship is created by its use. Any description of an outcome (such as a dismissal, settlement, or consent judgment) is a general summary, not a legal determination. All patents, trademarks, and company or law‑firm names are the property of their respective owners. PatSnap makes no warranty as to the accuracy or completeness of this content and disclaims, to the fullest extent permitted by law, all liability for reliance on it. For advice on a specific matter, consult qualified legal counsel.
PatSnap Eureka searches patents and litigation data to answer instantly.